Korea's Green Cross Sees Earnings Plunge As Flu Fears Wane
This article was originally published in PharmAsia News
Executive Summary
SEOUL - As widely expected, vaccine producer Green Cross, one of Korea's leading pharmas, has seen a sharp drop in its sales and net profit during the fourth quarter of last year